4.6 Editorial Material

Who Benefits From Transcatheter Edge-To-Edge Mitral Valve Repair and Who Does Not The Enigma Continues

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 14, Issue 4, Pages 753-755

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2020.07.038

Keywords

mitral regurgitation; outcomes; transcatheter mitral valve therapy

Funding

  1. Abbott Vascular
  2. Boston Scientific
  3. Cardiovalve
  4. Edwards Lifesciences
  5. W.L. Gore
  6. Medtronic

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available